| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 9 | 0.0014 |
| 1 | Microtubule Inhibitor [EPC] | 23 | 0.0001 |
| 2 | Orexin Receptor Antagonist [EPC] | 2 | 0.0001 |
| 3 | Platinum-based Drug [EPC] | 18 | 0.0001 |
| 4 | CTLA-4-directed Blocking Antibody [EPC] | 3 | 0.0001 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 6 | 0.0001 |
| 6 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 11 | 0.0001 |
| 7 | Topoisomerase Inhibitor [EPC] | 3 | 0.0000 |
| 8 | Alkylating Drug [EPC] | 3 | 0.0000 |
| 9 | Leukocyte Growth Factor [EPC] | 1 | 0.0000 |
| 10 | Folate Analog Metabolic Inhibitor [EPC] | 3 | 0.0000 |
| 11 | Kinase Inhibitor [EPC] | 3 | 0.0000 |
| 12 | Nucleoside Metabolic Inhibitor [EPC] | 1 | 0.0000 |
| 13 | Benzodiazepine [EPC] | 1 | 0.0000 |